BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7594585)

  • 1. Differential transcription efficiency of two Ig VH promoters in vitro.
    Buchanan KL; Hodgetts SI; Byrnes J; Webb CF
    J Immunol; 1995 Nov; 155(9):4270-7. PubMed ID: 7594585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family-specific differences in transcription efficiency of Ig heavy chain promoters.
    Buchanan KL; Smith EA; Dou S; Corcoran LM; Webb CF
    J Immunol; 1997 Aug; 159(3):1247-54. PubMed ID: 9233620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of cell-type-specific nuclear proteins with immunoglobulin VH promoter region sequences.
    Landolfi NF; Capra JD; Tucker PW
    Nature; 1986 Oct 9-15; 323(6088):548-51. PubMed ID: 3093895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional cooperativity between protein molecules bound at two distinct sequence elements of the immunoglobulin heavy-chain promoter.
    Poellinger L; Yoza BK; Roeder RG
    Nature; 1989 Feb; 337(6207):573-6. PubMed ID: 2492641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory elements in the promoter of a murine TCRD V gene segment.
    Kienker LJ; Ghosh MR; Tucker PW
    J Immunol; 1998 Jul; 161(2):791-804. PubMed ID: 9670956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction and functional interference of C/EBPbeta with octamer factors in immunoglobulin gene transcription.
    Hatada EN; Chen-Kiang S; Scheidereit C
    Eur J Immunol; 2000 Jan; 30(1):174-84. PubMed ID: 10602039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-specific, octamer-dependent costimulation of kappa transcription.
    Liberg D; Sigvardsson M; Bemark M; Leanderson T
    J Immunol; 1998 Apr; 160(8):3899-907. PubMed ID: 9558096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early B cell factor interacts with a subset of kappa promoters.
    Sigvardsson M; Akerblad P; Leanderson T
    J Immunol; 1996 May; 156(10):3788-96. PubMed ID: 8621915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C/EBP family of transcriptional activators is functionally important for Ig VH promoter activity in vivo and in vitro.
    Cooper C; Johnson D; Roman C; Avitahl N; Tucker P; Calame K
    J Immunol; 1992 Nov; 149(10):3225-31. PubMed ID: 1431100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolutionarily conserved sequence upstream of the human Ig heavy chain S gamma 3 region is an inducible promoter: synergistic activation by CD40 ligand and IL-4 via cooperative NF-kappa B and STAT-6 binding sites.
    Schaffer A; Cerutti A; Shah S; Zan H; Casali P
    J Immunol; 1999 May; 162(9):5327-36. PubMed ID: 10228008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
    J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.
    Shah PC; Bertolino E; Singh H
    EMBO J; 1997 Dec; 16(23):7105-17. PubMed ID: 9384588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutated promoter of a human Ig V lambda gene segment is associated with reduced germ-line transcription and a low frequency of rearrangement.
    Stiernholm NB; Berinstein NL
    J Immunol; 1995 Feb; 154(4):1748-61. PubMed ID: 7836759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Sp family of transcription factors in the regulation of the human and mouse MUC2 gene promoters.
    Aslam F; Palumbo L; Augenlicht LH; Velcich A
    Cancer Res; 2001 Jan; 61(2):570-6. PubMed ID: 11212251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional synergism of STAT6 with either NF-kappa B or PU.1 to mediate IL-4-induced activation of IgE germline gene transcription.
    Stütz AM; Woisetschläger M
    J Immunol; 1999 Oct; 163(8):4383-91. PubMed ID: 10510379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG box-activating factors 1 and 2, two HMG box transcription factors that bind the human Ig heavy chain enhancer.
    Stevens S; Ordentlich P; Sen R; Kadesch T
    J Immunol; 1996 Oct; 157(8):3491-8. PubMed ID: 8871648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Ig germ-line gamma 1 promoter. Involvement of C/enhancer-binding protein transcription factors and their possible interaction with an NF-IL-4 site.
    Lundgren M; Larsson C; Femino A; Xu M; Stavnezer J; Severinson E
    J Immunol; 1994 Oct; 153(7):2983-95. PubMed ID: 8089482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.